The fund is to generate long-term capital appreciation by providing equity investments to innovation and technology-related companies founded by entrepreneurs in the Greater Bay Area or operating from the Greater Bay Area at the start-up, growth and expansion phases of the lifecycle.

The Alibaba Hong Kong Entrepreneurs Fund (“AEF”) is a non-profit initiative launched by Alibaba Group in 2015. To vitalize the development of innovation and technology, AEF’s mission is to help Hong Kong entrepreneurs and young people realize their dreams and visions for a Hong Kong that is vibrant and engaged regionally and globally. As part of its investment program, AEF provides Hong Kong-based entrepreneurs with investment capital and strategic guidance to help them grow their businesses and penetrate global markets, by utilizing Alibaba's vast ecosystem.

AlphaTrio is an Asian impact fund focusing on Green Tech, Agrifood Tech and Financial inclusion. Our vision is to empower technology companies to create scalable impact and innovative solutions for the most pressing environmental and social challenges

Beyond Ventures is a Hong Kong-based venture capital fund established by eGarden Ventures in partnership with locally-grown serial entrepreneurs in 2017. eGarden Ventures is a venture capital fund focused on technology, media and telecoms (TMT) and holds nearly 20 years investment track record in Mainland China. The fund is also supported by leading investment company, Hony Capital, which manages more than US$10 billion in assets.

Adopting the slogan "From Hong Kong. For Hong Kong", Beyond Ventures seeks to revitalise Hong Kong's innovation ecosystem by bringing experienced venture and private equity funds together with successful entrepreneurs able to provide start-ups with mentoring support.

Beyond Ventures focuses on investments in artificial intelligence, biotechnology, chips, consumer electronics and platform businesses.

BioVeda China Fund (BVCF) since 2005 has been dedicated to creating and developing innovative global Chinese Life Sciences companies to benefit the health and wealth of the World.
BVCF has attracted global institutional financial and strategic investors to achieve this goal.
It is BVCF’s vision to grasp on opportunities and help place China to build global life science giants in the next few decades.
Forward-looking investment strategy was based on keen insight into technology, policy and the market opportunities with a seasoned investment team.

CASSTAR is the first investment company to propose the concept of “Key & Core Technology”. It also has established the first professional platform of investment and incubation for Key-technology startups in China. CASSTAR aims to provide entrepreneurs with professional, extensive, comprehensive startup incubation and financing solutions, which could create a tech-startup ecosystem that brings research institutions, early stage investment, entrepreneurial platform and post-investment services together. At the same time, CASSTAR explores science popularization and science education, undertakes social responsibilities, promotes industrialization of scientific and technological achievements and encourages deep integration of science and society. CASSTAR is currently based in Xi’an and Beijing.

An investment vehicle of Taiwan’s Chailease Group with a focus in medical technology and technology companies

China Prosperity Capital was established in 2015 and headquartered in Shenzhen with offices in Beijing and Hong Kong. We focus on investing growth stage and mature companies in TMT, pan-entertainment, and other related sectors. We pay close attention to how internet brings innovation to traditional business model, and the change of people’s lifestyle driven by technology advancement. Moreover, we dedicate to exploring and investing the startups which have wide market prospects, distinctive business model and excellent entrepreneur team. We are willing to help entrepreneurs overcome the difficulties in their road to development and share the joy of the growth.

Established in 2011, Cloudview Capital is a leading alternative asset management platform committed to creating excellent investment returns for its investors by providing its portfolio companies with well-rounded and value-adding management and financial advices in order to achieve higher shareholder value. After over a decade of development, Cloudview Capital’s AUM has surpassed US$5bn with over 70 portfolio companies. The team has around 50 professionals with offices in Beijing, Hong Kong, Hangzhou and Zhuhai.

Cloudview Capital has focused its investments in key industries including semiconductor, renewable energy, consumer durables and healthcare.

In-depth industry knowledge and strong network with existing portfolio companies enabled Cloudview Capital to source proprietary transactions, conduct thorough due diligence and create significant value through portfolio management.

Based in Hong Kong, Great Eagle Venture Capital invests globally in forward-thinking and cutting-edge deep technologies with the potential to change the world as well as partners with exceptional founders from the global entrepreneurial community. Areas of interest include but not limited to SaaS, AI, fintech, biotech, pharmaceutical, semiconductor, and environmental technologies. Notable investment includes Lucid, the American electric vehicle manufacturer and a Tesla rival.

Greater Bay Area Homeland Development Fund (“The Fund”) was jointly established by international large-scale industrial institutions, financial institutions and new economic enterprises. The Fund is set up to grasp the historical opportunities of the development of Guangdong-Hong Kong-Macao Greater Bay Area, and the construction of an International Innovation and Technology Hub, focusing on technological innovation, industrial upgrading, quality of life, smart city and all other related industries. The Fund covers venture capital, private equity investment, listed company investment, M&A investment and so on to offer financial support for outstanding entrepreneurs and enterprises, connecting industrial and financial resources, achieving long-term returns for shareholders and investors, and contributing positively to economic and social development.

In April 2013, InnoAngel Fund was jointly founded by Tsinghua alumni Li Zhu and Lin Sen. The investment management team has an average of over a decade of experience in angel investment. It has invested in over 400 venture projects and is managing over 3 billion RMB.

Hong Kong Inno Angel Fund was jointly sponsored by InnoAngel Fund and the Hong Kong–Shenzhen United Investment Fund in 2016. Together with local research institutes, accelerators and angel investment institutions, Hong Kong Inno Angel Fund works in conjunction with the Inno Ecosystem to help top quality startups enter the Mainland of China and South East Aisa markets.

Hong Kong X Technology Fund focus on early stage technology startup in Hong Kong and Greater Bay Area. Investment focus areas include Big data, Artificial Intelligence, Robotics, Biotechnology, Medical Science, Medicine, Microelectronics, Materials, Energy and FinTech. Hong Kong X Technology Fund is also a co-investment partner of HKSAR ITVF.

Huagai Capital was established in 2012 and is a private equity investment institution jointly founded by a group of professionals from well-known investment institutions both domestically and internationally. At present, the company manages assets of approximately 20 billion RMB. The company has a vision of becoming the most trusted capital partner for entrepreneurs and investors, focusing on private equity investment in the fields of healthcare and technology, and is committed to promoting the growth of small and medium-sized enterprises as industry leaders. The early stage technology investment fund mainly focuses on investment in intelligent manufacturing, intelligence logistics, advanced materials, and AI fields

Isola Capital Asset Management Limited, headquartered in Hong Kong, is a subsidiary of Isola Wealth Limited and an affiliate of Isola Capital Group. Isola is registered with the Hong Kong SFC and is licensed to conduct Type 1 (dealing in securities), Type 4 (advising on securities) and Type 9 (asset management) regulated activities in Hong Kong. Isola is an institutional grade platform that provides a range of proprietary investment strategies across venture and growth capital, private equity, private credit and liquid secondary markets. Through Isola’s current VC and PE focused fund, IPVF VII, Isola is particularly interested in potential investment opportunities with a clear use case in Hong Kong / Greater Bay Area, as well as global application.

Founded in 2010, K2VC is an early-stage venture capital firm focusing on investments in technology upgrade, business model innovation and consumer lifestyle revolution.
K2VC has invested in over 600 companies across Technology, Internet, Consumer, Healthcare and diverse industry verticals.

Lenovo Capital and Incubator Group (LCIG) is Lenovo’s global technology industrial fund. They aim to explore and accelerate startup companies utilizing Lenovo global team and resources and lay the ground for Lenovo’s smart Internet ecosystem. The key investment fields include cloud computing and big data, AI and robotics, AR/VR, +Internet, and consumption upgrade. Their portfolio companies include subsidiaries of SHAREit, Online Biometric Authentication, Lenovo Smart Healthcare, Enterprise Cloud, Lenovo New Glass, Lenovo Connect, Lenovo Big Data and Lenovo Finance, and more than 100 promising invested companies such as Megvii (Face++), NIO, Cambricon, Tuhu, Mobike, iDreamSky, Watrix Technology.

Linear Capital was founded in 2014 and has been focusing on investing in the space of "frontier technology + industry", that is, frontier technology represented by data intelligence, next-generation infrastructure, next-generation robot technology, and technological transformations of traditional industries such as biomedicine, materials, energy, etc. Frontier technology is applied to various verticals to significantly improve industry productivity, solve the pain points, complete industry upgrading, and achieve attractive returns by substantially increasing industry value. Linear Capital persists in investing in the early stage and continuing to provide support throughout the investment life cycle. At present, Linear Capital is managing ten funds with a total AUM of about US$2 billion. Linear Capital has invested in the early stage of more than 120 entrepreneurial teams including Horizon Robotics, Kujiale, Sensors Data, Tezign, Agile Robots, Thinking Data, Rokid, Guanyuan Data, Tophant, etc. The total valuation of Linear Capital's portfolio companies is estimated to be about US$20 billion.

MindWorks Capital invests in and empowers Asia’s brightest entrepreneurs to build transformational companies. MindWorks manages capital from university endowments, global asset managers, funds of funds, family offices, and Asia's leading new economy entrepreneurs. The firm utilizes a Pan-Asia strategy to source direct investments in technology companies across both Greater China and Southeast Asia. Founded in 2013, the firm is headquartered in Hong Kong with offices in Beijing, Shanghai and Jakarta. MindWorks has been recognized by Preqin as a top-performing ASEAN venture capital firm and is also a signatory of the United Nations’ Principles for Responsible Investment.

QBN Capital is a venture capital fund based in Hong Kong with a mission to foster innovation in technology by facilitating global talent and business exchanges. Our areas of interest include FinTech, Digital Assets, DeepTech, and Semiconductor. Along with providing growth capital, we offer strategic advice and access to our extensive network of investors and business partners. Our priority is to provide long-term support to help companies achieve their full potential.

Established in 2004, Chengwei Capital invests in companies that have scalable business opportunities in the global Chinese economy. Its portfolio investments includes over 180 companies operating in a wide range of industries such as manufacturing, consumer goods, education, the internet, and oil and gas. They have a strong track record.

VU Venture Partners is a global venture capital fund focusing on the world’s largest opportunities. VU is a long term capital partner throughout a portfolio company's journey, with the capability to lead and participate in multiple follow-on rounds. VU has access to the global startups, corporate, and investor ecosystem through its proprietary insider investor network at an unprecedented scale VU accelerates the growth and success of its portfolio companies by actively supporting customer acquisition, partnerships, capital raising, hiring, marketing, and exit strategies.

Founded in 2015, GT Healthcare Capital Partners is an Asia-based private investment partnership that specializes in healthcare investments around the globe that aim to change technology landscapes. GT Healthcare intends to provide capital and scale expertise to healthcare businesses in Asia / Greater China. GT Healthcare is a patient-oriented healthcare innovator with a vision of bringing effective and affordable options to patients globally. Their mission is to invest in healthcare and bring value to investors, entrepreneurs, healthcare providers, and most importantly, patients.

BV launched by Baidu as Baidu Ventures , an independent venture capital firm for innovative founders. BV focus on the distribution and exploration of artificial intelligence. As the one of the venture capitals which delve into the field of artificial intelligence earlier than others, based on AI, BV’s portfolios cover artificial intelligence industry chain, Self-driving automobile, Medical, Life science, Robotics, Advanced computing, etc. Today, BV has over 700 million dollars funds, 200 active portfolio companies across world. In the future, BV will continue to explore and accompany emerging technology companies to grow, provide entrepreneurs with professional technical support and globalized resource empowerment, and help their technology breakthroughs and innovations to achieve long-term business value.

Established in 2011, HAX is a part of SOSV, which is a venture capital firm which provides multi-stage investment to support founders ideas. HAX focused on hardware companies, which have engineering or scientific breakthroughs in the physical world to unlock massive industry opportunities. HAX has a unique model which combines investment capital with hands-on development support from deeply experienced engineering and design team, 6-month residency in HAX’s equipped facilities and the access to a global network of manufacturers, mentors and talents.​

Established in 2022, Clearwater Bay Fund has been funded by Sequoia China, Shenzhen Tencent Industrial Fund and Prof Li Zexiang. Clear Water Bay Fund was originally initiated by Prof. Li Zexiang, Professor of ECE HKUST. ​Prof. Li was named the “Godfather of Hidden Entrepreneurship in China”. He co-founded Googol, and DJI and nurtured CiDi, Hai Robotics and Ecoflow.

The Company is a licensed corporation under the Hong Kong Securities and Futures Ordinance to carry out regulated activities Type 9 “Asset management” under the Hong Kong Securities and Futures Ordinance. The principal activities of the Company are engaged in provision of asset management.

Saltagen Ventures is an early-stage venture capital firm that invests in science and technology-based startups with an investment strategy focusing on biotechnology, AI & machine learning, edtech and media technology. We look for startups that are built around a core of deeptech research. These startups can benefit from our deep networks in specific verticals and expertise on both sides of the Pacific enabled by our experienced investment team and ecosystem partners. We empower startups to grow their business and develop efficiencies across borders via Canada and Hong Kong as a strategic base

Oriza Seed is a professional early-stage equity investment platform of Oriza Holdings, focusing on investing early-stage and growth-stage start-ups in the Healthcare and TMT industries. Oriza Seed manages VC funds and angel funds with over 5 billion assets under management. Oriza Seed has been widely recognized by early hi-tech start-ups and entrepreneurs. By now, Oriza Seed has supported more than 200 companies, including Ascentage pharma, CStone Pharmaceuticals, Juno Therapeutics, Basecare, Biocytogen, Singleron, BR Robot, Tztek, Cambricon, Cloudwalk, WeRide, etc.

Spark Ventures was founded after years of working in the business and investment industry. Their goal is to help entrepreneurs turning their own ideas and visions into successful companies with fundraising and networking guidance.

Spark Ventures is a venture capital firm that invests in startups which comprise disruptive enterprise technology, Asia-based, early and expansion stage and innovative infrastructure.

Their investment in business is more than just financial. Spark Ventures involved in helping innovative startups reach their full potential. When they commit to working with a company, they become partners and lend full support behind their efforts to move their company forward.

Spark Ventures partner with best-in-class innovators and strong investment syndicate partners at the seed stage to early stage of a company’s development. Unlike many seed investors, they continue investing across future rounds in their successful portfolio companies.

T12M Ventures (T12M) is principally engaged in early stage venture investments within the technology sector, particularly the information technology and digital industries. T12M is based in Hong Kong and engages in angel, seed, and pre-A venture deals across Hong Kong and Asia. T12M's portfolio is highly-synergised to adopt a digital-first strategy with a mission to uplift the technology innovation and adoption in Hong Kong.

Transcend Capital Partners II is an ESG-conscious venture capital fund focusing on startups with gender-balanced teams in Asia. These two investment pillars are observed by the fund’s mandate for >50% of committed capital to be invested in startups with women in senior management, and the fund’s use of an ESG criteria for screening. The fund specializes in series B or earlier equity financing across Asia.
Transcend Capital Partners was founded by a group of experienced entrepreneurs, investors and corporate financial professionals who have gone through the startup, expansion, fundraising and exit cycle. Prior to founding Transcend Fund I and Fund II, the partners have helped corporates raise more than US$50 billion via equity placements, debt financing and IPOs. Transcend serves as a platform for like-minded investors to converge, share investment insights and invest.

Verge is an early stage venture capital firm that focuses on HealthTech startups around the globe. We invest in transformative technology that makes healthcare accessible, better in quality and efficiency, and reaches the underserved markets in Asia and beyond. Established in 2018, the Team has made investments in 49 HealthTech startups from 20 countries.

Established in 2011, ZhenFund is among the first crop of angle investment firms to open up in China. There are current 12 billion yuan in assets under management. Over the years, we have dedicated ourselves to the empowerment of young and aspiring entrepreneurs, fueling their journey towards an innovative and prosperous future. Zhenfund has laid the foundations on which hundreds of companies, across many industries, have achieved their metamorphosis from zero to one.